Evidence map›Paper›PMID 42244491›Full record

ArticleInternational forum of allergy & rhinology2026

Assessment of MUcociLiary Transport timE in CRSwNP Patients in Treatment With Dupilumab: AMULET Study.

Alessia Giorli, Fabio Ferretti, Antonio Romano, Marco Casiraghi, Mariella Scarano, Paolo Farneti, Giacomo Sollini, Marco Mandalà, Ernesto Pasquini, Cesare Biagini

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International forum of allergy & rhinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Alessia GiorliDepartment of Otorhinolaryngology and Head and Neck Surgery, Azienda Ospedaliero-Universitaria Senese, Siena, Italy.ORCID https://orcid.org/0009-0008-2131-3328
Fabio FerrettiDepartment of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy.
Antonio RomanoDepartment of Otorhinolaryngology and Head and Neck Surgery, Azienda Ospedaliero-Universitaria Senese, Siena, Italy.
Marco CasiraghiDepartment of Otorhinolaryngology and Head and Neck Surgery, Azienda Ospedaliero-Universitaria Senese, Siena, Italy.
Mariella ScaranoDepartment of Otorhinolaryngology and Head and Neck Surgery, Bellaria Hospital, AUSL Bologna, Bologna, Italy.
Paolo FarnetiDepartment of Otorhinolaryngology and Head and Neck Surgery, Bellaria Hospital, AUSL Bologna, Bologna, Italy.
Giacomo SolliniDepartment of Otorhinolaryngology and Head and Neck Surgery, Bellaria Hospital, AUSL Bologna, Bologna, Italy.ORCID https://orcid.org/0000-0002-6536-0184
Marco MandalàDepartment of Otorhinolaryngology and Head and Neck Surgery, Azienda Ospedaliero-Universitaria Senese, Siena, Italy.
Ernesto PasquiniDepartment of Otorhinolaryngology and Head and Neck Surgery, Bellaria Hospital, AUSL Bologna, Bologna, Italy.
Cesare BiaginiDepartment of Otorhinolaryngology and Head and Neck Surgery, Azienda Ospedaliero-Universitaria Senese, Siena, Italy.

Funding

Sanofi Regeneron SGZ-2022-13785
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biological treatmentchronic rhinosinusitisnasal mucosanasal polypstype‐2 inflammation

Identifiers

PMID42244491
PMCPMC13432524

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.